Breaking News Instant updates and real-time market news.

NKE

Nike

$81.88

2.15 (2.70%)

, QCOM

Qualcomm

$66.02

-0.06 (-0.09%)

10:29
08/20/18
08/20
10:29
08/20/18
10:29

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Positive from Neutral at Susquehanna and to Overweight from Neutral at Piper Jaffray. 2. Qualcomm (QCOM) upgraded to Buy from Neutral at Rosenblatt with analyst Jun Zhang citing benefits from 5G smartphone growth over the next few years. 3. Flir Systems (FLIR) upgraded to Outperform from Market Perform at William Blair with analyst Louie DiPalma he believes, in the near-term, Flir's enhanced automation and software capabilities are rendering its sensors more powerful and driving adoption. Additionally, DiPalma believes thermal sensors will be common in autonomous vehicles over the longer term, which could be a major source of long-term upside. 4. RBS (RBS) upgraded to Buy from Neutral at Citi. 5. Terex (TEX) upgraded to Neutral from Underperform at Baird with analyst Mig Dobre citing its recent pullback and multiple compression as well as its upcoming investors day. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NKE

Nike

$81.88

2.15 (2.70%)

QCOM

Qualcomm

$66.02

-0.06 (-0.09%)

FLIR

Flir Systems

$61.07

0.89 (1.48%)

RBS

RBS

$6.33

0.075 (1.20%)

TEX

Terex

$38.98

0.61 (1.59%)

  • 12

    Sep

  • 06

    Nov

NKE Nike
$81.88

2.15 (2.70%)

08/20/18
SUSQ
08/20/18
UPGRADE
Target $93
SUSQ
Positive
Nike upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains and gains within the family footwear channel. The gains are due to improved product offerings and product flow, putting the company on pace to meet its 2023 $50B revenue target, said Poser. He raised his price target to $93 from $78 on Nike shares.
08/16/18
08/16/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ARGUS SAYS BUY LULULEMON: Argus analyst John Staszak upgraded Lululemon (LULU) to Buy from Hold with a price target of $150, citing the company's Q1 earnings beat and expectations of improved comps in Q2, along with its "substantial" growth opportunities to expand its brand overseas and particularly in China. Staszak contends that Lululemon's growth prospects are "among the best in the apparel sector," with a transition to higher margin e-commerce sales seen expanding its operating margins in the coming several years. The analyst further notes that his implied price target valuation multiple of 44-times forward earnings is within the multiple range of companies like Nike (NKE), Under Armour (UA), and VF Corp. (VFC) and justified by its rapid e-commerce adoption and strong overall growth. KIMBERLY-CLARK RAISED AFTER PRICE HIKES: JPMorgan analyst Andrea Teixeira upgraded shares of Kimberly-Clark (KMB) to Neutral from Underweight and raised her price target to $114 from $90 following yesterday's announcement that the company will increase prices or reduce package counts on key products in North America. The analyst notes that while it remains to be seen if the price increases will "actually hold" given the intensely competitive U.S. market, she believes investors will give Kimberly-Clark shares the benefit of the doubt. Additionally, she tells investors that Procter & Gamble's (PG) commentary that it plans to raise prices on some of its premium paper products and diapers is "supportive" of Kimberly-Clark's ability to pass on higher prices. COTY CUT TWO NOTCHES AT MERRILL: BofA Merrill Lynch analyst Olivia Tong double downgraded Coty to Underperform from Buy and cut its price target to $10 from $16. Tong said Coty is now more exposed to the mass beauty market following its merger with 41 brands from PG Beauty and is seeing disruption from smaller, niche brands and newer distribution channels. ACTIVISION PULLBACK SEEN AS OPPORTUNITY: Jefferies analyst Timothy O'Shea said he views China having frozen mobile game approvals as a temporary problem and "mostly a non-issue" as only the monetization approval process has been frozen, not the content approval process, and he notes administrators are already implementing a fast-track approval process to alleviate the problem. Activision Blizzard (ATVI) has a pipeline of new mobile games coming that he would still expect to launch in China over time and O'Shea sees the 15% pullback in the game maker's shares in the last month as a buying opportunity, he tells investors. He maintains a Buy rating and $90 price target on Activision shares.
08/20/18
PIPR
08/20/18
UPGRADE
Target $93
PIPR
Overweight
Nike upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Erinn Murphy upgraded Nike to Overweight from Neutral and raised her price target for shares to $93 from $72, telling investors in a research note that she believes the risk profile of owning Nike shares has "considerably diminished" and sees Nike moving from downward EPS revisions to upward revisions supported by a stabilizing North America landscape, strong margin and sales drivers and improving brand momentum. Murphy sees EPS power for 2023 to greater than $5.60/share amid the "extremely healthy" athletic category.
08/20/18
SUSQ
08/20/18
UPGRADE
SUSQ
Positive
Nike upgraded to Positive from Neutral at Susquehanna
QCOM Qualcomm
$66.02

-0.06 (-0.09%)

08/06/18
COWN
08/06/18
UPGRADE
Target $80
COWN
Outperform
Qualcomm upgraded to Outperform at Cowen
As reported previously, Canaccord analyst Matthew Ramsay upgraded Qualcomm to Outperform from Market Perform. The analyst noted the company's $30B buyback and believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. Ramsay raised his price target to $80 from $64 on Qualcomm shares.
08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
08/20/18
RSBL
08/20/18
UPGRADE
Target $70
RSBL
Buy
Qualcomm upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Jun Zhang upgraded Qualcomm (QCOM) to Buy from Neutral and increased its price target to $70 from $57 citing benefits from 5G smartphone growth over the next few years, Zhang said Qualcomm's 5G RF module is better positioned than their 4G product and should continue to gain share in the high-end market due to MediaTek's smartphone chipset roadmap losing traction. Additionally, Qualcomm should see a signifcant ramp in other products such as finger print sensors and believes Apple (AAPL) may still rely on Qualcomm's 5G modem over Intel's (INTC), the analyst wrote in a note to investors.
08/06/18
08/06/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Overweight from Neutral at Atlantic Equities with analyst Hamilton Faber saying he believes "the bulk of the M&A storm" has passed. 2. Qualcomm (QCOM) upgraded to Outperform from Market Perform at Cowen with analyst Matthew Ramsay citing the company's $30B buyback and saying he believes the shares offer a compelling risk/reward with effects of lower spending, solid customer performance, and potential QTL resolutions. 3. Square (SQ) upgraded to Buy from Neutral at Buckingham with analyst Chris Brendler saying the Q2 strong results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better-then-expected core revenue growth into 2020. 4. Parker-Hannifin (PH) upgraded to Outperform from In Line at Evercore ISI with analyst David Raso saying the company's recent operational struggles are behind it with this quarters report and views 2019 guidance as conservative. 5. Intercept (ICPT) upgraded to Buy from Sell at Goldman Sachs with analyst Salveen Richter saying Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FLIR Flir Systems
$61.07

0.89 (1.48%)

07/30/18
SPHN
07/30/18
NO CHANGE
Target $69
SPHN
Overweight
Flir Systems price target raised to $69 from $61 at Stephens
Stephens analyst Drew Lipke said Flir Systems continues to post "impressive" organic growth in its Government and Defense and Industrial segments, while he believes the company starts to see the first evidence of benefits from its productivity and working capital initiatives. He thinks the stock warrants a premium multiple and raised his price target on Flir shares to $69 from $61 following the company's Q2 earnings report while maintaining an Overweight rating.
08/20/18
WBLR
08/20/18
UPGRADE
WBLR
Outperform
Flir Systems upgraded to Outperform from Market Perform at William Blair
08/20/18
WBLR
08/20/18
UPGRADE
WBLR
Outperform
Flir Systems upgraded to Outperform from Market Perform at William Blair
As previously reported, William Blair analyst Louie DiPalma upgraded Flir Systems to Outperform from Market Perform after conducting industry checks and meeting with management. In the near-term, DiPalma believes Flir's enhanced automation and software capabilities are rendering its sensors more powerful and driving adoption. Additionally, DiPalma believes thermal sensors will be common in autonomous vehicles over the longer term, which could be a major source of long-term upside.
08/01/18
IMPC
08/01/18
NO CHANGE
Target $60
IMPC
In-Line
Flir Systems price target raised to $60 from $53 at Imperial Capital
Imperial Capital analyst Jeff Kessler raised his price target for Flir Systems to $60 following the company's better than expected Q2 results. Contributions from internal and sales programs will become significant for Flir beginning in 2019, Kessler tells investors in a research note. He maintains an In-Line rating on the shares.
RBS RBS
$6.33

0.075 (1.20%)

08/10/18
08/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AMD (AMD) upgraded to Neutral from Sell at Goldman Sachs with analyst Toshiya Hari saying Intel's (INTC) struggles with 10nm process technology make it increasingly harder to argue for a bear thesis, even following the recent rally in the shares. 2. RBS (RBS) upgraded to Buy from Neutral at UBS with analyst Jason Napier saying the bank's capital strength is being undervalued by the market. 3. Dropbox (DBX) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney citing "strong" Q2 results and above consensus guidance. 4. Sanofi (SNY) upgraded to Buy from Neutral at Citi. 5. Floor & Decor (FND) upgraded to Outperform from Market Perform at Wells Fargo with analyst Zachary Fadem saying he believes current share levels represent a "compelling long-term entry point for one of the best growth stories in all of retail." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
UBSW
08/10/18
UPGRADE
UBSW
Buy
RBS upgraded to Buy from Neutral at UBS
UBS analyst Jason Napier upgraded RBS Group to Buy saying the bank's capital strength is being undervalued by the market.
06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/20/18
SBSH
08/20/18
UPGRADE
SBSH
Buy
RBS upgraded to Buy from Neutral at Citi
TEX Terex
$38.98

0.61 (1.59%)

07/19/18
07/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Hold at Needham with analyst Rajvindra Gill saying the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at UBS with analyst Steven Strycula saying the company's reinvestment cycle limits earnings and stock upside. 3. Terex (TEX) downgraded to Market Perform from Outperform at Wells Fargo with analyst Andrew Casey saying his crane check was good but not great, with demand appearing to sequentially flatten. 4. Spark Therapeutics (ONCE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Kennen MacKay saying that after a strong run-up in the stock price driven by lofty expectations for the ongoing Phase 1/2 trial of SPK-8011 in patients with hemophilia, achieving mean FVIII expression levels of 30-55% anticipated by the Street could prove "challenging" as "data to date has not indicated clear dose responsiveness." 5. Hyatt (H) downgraded to Hold from Buy at Berenberg with analyst El Kassir saying Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
08/20/18
BARD
08/20/18
UPGRADE
BARD
Neutral
Terex upgraded to Neutral from Underperform at Baird
08/20/18
BARD
08/20/18
UPGRADE
Target $38
BARD
Neutral
Terex upgraded to Neutral at Baird
As reported previously, Baird analyst Mig Dobre upgraded Terex to Neutral from Underperform. The analyst cited its recent pullback and multiple compression as well as its upcoming investors day. Dobre maintained his $38 price target on Terex shares.

TODAY'S FREE FLY STORIES

OBLN

Obalon Therapeutics

$1.24

0.842 (211.56%)

17:41
05/22/19
05/22
17:41
05/22/19
17:41
Hot Stocks
Obalon Therapeutics discloses resignation of CEO »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVA

Granite Construction

$41.37

-0.09 (-0.22%)

17:39
05/22/19
05/22
17:39
05/22/19
17:39
Hot Stocks
Granite Construction acquires additional trenchless rehabilitation assets »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

NVCN

Neovasc

$0.48

-0.0023 (-0.48%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Hot Stocks
Neovasc discloses International Journal of Cardiology review of Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Periodicals
Pentagon mulls request to send 5,000 U.S. troops to Middle East, Reuters says »

The U.S. Department of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$183.36

-0.52 (-0.28%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Pool Corp. Chairman John Stokely sells almost $2M in company shares »

Pool Corp. Chairman John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 18

    Jun

  • 13

    Nov

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Raytheon awarded $151.47M Navy contract for AIM-9X missile sustainment »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

ESV

Ensco Rowan

$10.01

-0.365 (-3.52%)

17:31
05/22/19
05/22
17:31
05/22/19
17:31
Hot Stocks
Ensco Rowan says will not pay a regular quarterly cash dividend »

Ensco Rowan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$171.29

1.67 (0.98%)

, GILD

Gilead

$66.51

-0.01 (-0.02%)

17:30
05/22/19
05/22
17:30
05/22/19
17:30
Upgrade
Amgen, Gilead, Alexion, Vertex, BioMarin, Biogen, Regeneron rating change  »

Citi assumes coverage of…

AMGN

Amgen

$171.29

1.67 (0.98%)

GILD

Gilead

$66.51

-0.01 (-0.02%)

ALXN

Alexion

$127.47

-1.33 (-1.03%)

VRTX

Vertex

$172.37

3.22 (1.90%)

BMRN

BioMarin

$87.80

0.33 (0.38%)

BIIB

Biogen

$234.98

2.04 (0.88%)

REGN

Regeneron

$320.00

10.19 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 28

    Jun

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

, BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

17:24
05/22/19
05/22
17:24
05/22/19
17:24
Hot Stocks
BBX Capital says will not proceed with merger with Bluegreen Vacations »

BBX Capital (BBX)…

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:21
05/22/19
05/22
17:21
05/22/19
17:21
Hot Stocks
Raytheon awarded $234.64M Navy contract »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

WEX

Wex

$203.30

-1.56 (-0.76%)

17:20
05/22/19
05/22
17:20
05/22/19
17:20
Hot Stocks
Wex CEO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

RTLR

Rattler Midstream

$0.00

(0.00%)

17:19
05/22/19
05/22
17:19
05/22/19
17:19
Syndicate
Rattler Midstream 38M share IPO priced at $17.50 »

The IPO was upsized to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

GILD

Gilead

$66.51

-0.01 (-0.02%)

17:19
05/22/19
05/22
17:19
05/22/19
17:19
Upgrade
Gilead rating change  »

Gilead upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SERV

ServiceMaster

$54.18

-0.1 (-0.18%)

17:18
05/22/19
05/22
17:18
05/22/19
17:18
Hot Stocks
ServiceMaster director sells 8.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 18

    Jun

AMGN

Amgen

$171.29

1.67 (0.98%)

17:18
05/22/19
05/22
17:18
05/22/19
17:18
Upgrade
Amgen rating change  »

Amgen upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SBLK

Star Bulk Carriers

$8.13

-0.13 (-1.57%)

17:17
05/22/19
05/22
17:17
05/22/19
17:17
Earnings
Star Bulk Carriers reports Q1 EPS (9c), consensus (4c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

IBM

IBM

$136.34

-0.12 (-0.09%)

17:14
05/22/19
05/22
17:14
05/22/19
17:14
Hot Stocks
IBM awarded $275M DMEA contract »

IBM has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

AVP

Avon Products

$3.49

0.295 (9.23%)

17:09
05/22/19
05/22
17:09
05/22/19
17:09
Hot Stocks
Avon Products jumps another 16% after Natura confirms deal »

Shares of Avon are up 56c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$41.72

0.02 (0.05%)

17:05
05/22/19
05/22
17:05
05/22/19
17:05
Upgrade
HSBC rating change  »

HSBC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

AVP

Avon Products

$3.49

0.295 (9.23%)

17:04
05/22/19
05/22
17:04
05/22/19
17:04
Hot Stocks
Natura confirms Avon Products deal with combined group's enterprise value $11B »

Natura &Co announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITE

SiteOne Landscape

$64.36

-2.095 (-3.15%)

17:02
05/22/19
05/22
17:02
05/22/19
17:02
Hot Stocks
SiteOne Landscape acquires Stone and Soil Depot in San Antonio »

SiteOne Landscape…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 05

    Jun

RJF

Raymond James

$85.16

-0.64 (-0.75%)

16:53
05/22/19
05/22
16:53
05/22/19
16:53
Hot Stocks
Breaking Hot Stocks news story on Raymond James »

Raymond James reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$67.08

-2.93 (-4.19%)

16:45
05/22/19
05/22
16:45
05/22/19
16:45
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp down 6% after Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 09

    Jul

YNDX

Yandex

$37.67

0.255 (0.68%)

16:43
05/22/19
05/22
16:43
05/22/19
16:43
Hot Stocks
Yandex appoints Tigran Khudaverdyan Deputy CEO »

Yandex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$9.21

-0.31 (-3.26%)

16:39
05/22/19
05/22
16:39
05/22/19
16:39
Syndicate
Breaking Syndicate news story on Prothena »

Prothena files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.